Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-220
Closed -$42.9K – 926
2026
Q2
$42.9K Hold
220
– – ﹤0.01% 534
2026
Q1
$49.4K Buy
220
+15
+7% +$3.74K ﹤0.01% 505
2025
Q4
$49.4K Sell
205
-47
-19% -$12K ﹤0.01% 499
2025
Q3
$69K Buy
252
+47
+23% +$12.8K ﹤0.01% 469
2025
Q2
$52.9K Hold
205
– – ﹤0.01% 495
2025
Q1
$45.9K Hold
205
– – ﹤0.01% 502
2024
Q4
$46.9K Hold
205
– – ﹤0.01% 507
2024
Q3
$50K Buy
+205
New +$45.8K ﹤0.01% 523

Other funds holding RMD

NBT Bank's RMD Position: Q3 2026 in Review

NBT Bank sold out of ResMed (RMD) in Q3 2026, closing a stake of 220 shares — an estimated $42.9K sold.

NBT Bank first reported a position in RMD in Q3 2024 and held it in 8 quarters. The position peaked at $69K in Q3 2025. 886 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • NBT Bank reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • NBT Bank sold 220 ResMed shares in Q3 2026, an estimated $42.9K.
  • NBT Bank first reported a position in ResMed in Q3 2024 and held it in 8 quarters.
  • NBT Bank's ResMed position peaked at $69K in Q3 2025.
  • 886 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on NBT Bank's 13F filing for Q3 2026, filed 21 Oct 2026.